U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders
U.S. Special Forces Intercept Ship Carrying Military Components Bound for Iran
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
Tunisia Protests Grow as Opposition Unites Against President Kais Saied’s Rule
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges 



